Profound Medical (PROF) Shares Outstanding (Weighted Average) (2018 - 2026)

Profound Medical's Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $36.3 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 20.82% year-over-year to $36.3 million; the TTM figure through Mar 2026 stood at $36.3 million (up 20.82% YoY), while the FY2025 annual figure was $30.2 million, up 22.08% from the prior year.
• Shares Outstanding (Weighted Average) was $36.3 million for Q1 2026 at Profound Medical, up from $30.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $36.3 million in Q1 2026 to a low of $772270.0 in Q4 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $25.2 million across 5 years, with a median of $24.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) tumbled 96.28% in 2022, then soared 2642.9% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $772270.0 in 2022, then jumped by 2642.9% to $21.2 million in 2023, then grew by 16.91% to $24.8 million in 2024, then grew by 22.08% to $30.2 million in 2025, then grew by 20.06% to $36.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $36.3 million (Q1 2026), $30.2 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.